|
FNDC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30919997065604E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.09819999947337E-08 |
| Normal-vs-Stage2 |
2.604000E-02 |
| Normal-vs-Stage3 |
6.408400E-02 |
| Normal-vs-Stage4 |
1.168800E-01 |
| Stage1-vs-Stage2 |
9.859600E-01 |
| Stage1-vs-Stage3 |
6.521700E-02 |
| Stage1-vs-Stage4 |
8.636600E-01 |
| Stage2-vs-Stage3 |
2.476000E-01 |
| Stage2-vs-Stage4 |
8.962800E-01 |
| Stage3-vs-Stage4 |
3.931200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.61360000495404E-08 |
| Normal-vs-AfricanAmerican |
1.006500E-04 |
| Normal-vs-Asian |
2.577200E-01 |
| Caucasian-vs-AfricanAmerican |
1.818570E-01 |
| Caucasian-vs-Asian |
5.498600E-01 |
| AfricanAmerican-vs-Asian |
9.962000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15250000046296E-07 |
| Normal-vs-Female |
5.23700000032434E-07 |
| Male-vs-Female |
8.768400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.404300E-04 |
| Normal-vs-Extreme_Weight |
9.86920000000113E-05 |
| Normal-vs-Obese |
3.826400E-04 |
| Normal-vs-Extreme_Obese |
1.215400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.109000E-01 |
| Normal_Weight-vs-Obese |
3.914200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.027200E-01 |
| Extreme_Weight-vs-Obese |
5.147800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.688800E-01 |
| Obese-vs-Extreme_Obese |
3.059600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.277190E-01 |
| Normal-vs-Age(41-60Yrs) |
3.31779999995785E-06 |
| Normal-vs-Age(61-80Yrs) |
2.73600000433305E-08 |
| Normal-vs-Age(81-100Yrs) |
1.518160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.309600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.368600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.621600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.566200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.857400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.765300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.02339997482193E-09 |
| Normal-VS-Type2 PRCC |
1.476890E-03 |
| Normal-VS-KIRP CIMP |
1.807510E-02 |
| Normal-VS-Unclassified PRCC |
4.230100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.058700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.62758695410048E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
8.580000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.51219999644914E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
4.189600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.36599999999809E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.323000E-03 |
| Normal-vs-N1 |
1.025980E-01 |
| Normal-vs-N2 |
4.338300E-03 |
| N0-vs-N1 |
1.509200E-01 |
| N0-vs-N2 |
9.260000E-01 |
| N1-vs-N2 |
2.058200E-01 |
|
|
